Table 1.
Open in new tab

Volume of anti-neuropathic agents’ turnover between 2017 and 2021.

20172018201920202021Percentage of change in turnover quarterly95% confidence intervalP value
Amitriptyline37387263220893478155634295716282162+23.6%1.4 to 45.9.038
Carbamazepine10506218137705906574148765580710301243–7.67%–19.6 to 4.2.091
Duloxetine28521401009245193563012485851647359–26.8%–66.9 to 13.2.176
Gabapentin54730654293454434781936146154111952–8%–22.65 to 5.44.215
Pregabalin55051998489312115416551230287815856253+60%37.6 to 82.5.0001
overall turnover2807534930783495291808082825145838198969+ 8.40%–1.7 to 18.5.098
20172018201920202021Percentage of change in turnover quarterly95% confidence intervalP value
Amitriptyline37387263220893478155634295716282162+23.6%1.4 to 45.9.038
Carbamazepine10506218137705906574148765580710301243–7.67%–19.6 to 4.2.091
Duloxetine28521401009245193563012485851647359–26.8%–66.9 to 13.2.176
Gabapentin54730654293454434781936146154111952–8%–22.65 to 5.44.215
Pregabalin55051998489312115416551230287815856253+60%37.6 to 82.5.0001
overall turnover2807534930783495291808082825145838198969+ 8.40%–1.7 to 18.5.098
Table 1.
Open in new tab

Volume of anti-neuropathic agents’ turnover between 2017 and 2021.

20172018201920202021Percentage of change in turnover quarterly95% confidence intervalP value
Amitriptyline37387263220893478155634295716282162+23.6%1.4 to 45.9.038
Carbamazepine10506218137705906574148765580710301243–7.67%–19.6 to 4.2.091
Duloxetine28521401009245193563012485851647359–26.8%–66.9 to 13.2.176
Gabapentin54730654293454434781936146154111952–8%–22.65 to 5.44.215
Pregabalin55051998489312115416551230287815856253+60%37.6 to 82.5.0001
overall turnover2807534930783495291808082825145838198969+ 8.40%–1.7 to 18.5.098
20172018201920202021Percentage of change in turnover quarterly95% confidence intervalP value
Amitriptyline37387263220893478155634295716282162+23.6%1.4 to 45.9.038
Carbamazepine10506218137705906574148765580710301243–7.67%–19.6 to 4.2.091
Duloxetine28521401009245193563012485851647359–26.8%–66.9 to 13.2.176
Gabapentin54730654293454434781936146154111952–8%–22.65 to 5.44.215
Pregabalin55051998489312115416551230287815856253+60%37.6 to 82.5.0001
overall turnover2807534930783495291808082825145838198969+ 8.40%–1.7 to 18.5.098
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close